Project Grant R01TW013180
- Federal Grant Award Summary Yale University received a $220,518 Project Grant from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989) to conduct research on persistent vascular dysfunction and cognitive outcomes among virally suppressed people with HIV (PWH). The award, effective September 1, 2025, through June 30, 2027, supports an empirical investigation into the relationship between cardiovascular disease (CVD), vascular brain...
- Federal Grant Award Summary The Fogarty International Center (FIC) awarded a $1.26 million Project Grant to the University of California, Los Angeles (UCLA) under the International Research and Research Training program (CFDA 93.989) to develop and evaluate a culturally adapted intervention addressing HIV-related stigma and treatment disengagement among treatment-naïve Indonesian people living with HIV (PLH). The award, dated August 20, 2025, with completion by July 31, 2028, supports UCLA's...
- Federal Project Grant Award Summary The Fogarty International Center (FIC) awarded Impact Research and Development Organisation (IRDO) a $234,292 Project Grant under the International Research and Research Training program (CFDA 93.989) on September 13, 2025, to develop and pilot test a multilevel, community-based intervention designed to reduce Pre-Exposure Prophylaxis (PrEP) stigma and increase PrEP uptake among adolescent girls and young women (AGYW) ages 15-24 in Western Kenya. The award,...
- Federal Grant Award Summary Yale University received a $658,019 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious diseases Research program (CFDA 93.855), effective August 20, 2025, through July 31, 2030. The award establishes the R3EDI (Rigorous, Rapid, & Relevant Evidence Adaptation & Implementation) Consultation Hub to End the HIV Epidemic (EHE), a technical assistance and resource center designed to advance...
- Federal Grant Award Summary Yale University received a $896,804 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop a comprehensive service planning tool addressing the interconnected HIV, hepatitis C virus (HCV), and opioid use disorder epidemics. The grant, awarded August 1, 2025, with a completion date of July 31, 2027, supports the creation of a cost-based epidemiological planning tool designed to identify...
- Federal Grant Award Summary The Johns Hopkins University received a $431,804 Project Grant from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) awarded September 15, 2025, with completion anticipated by June 30, 2028. This award supports the adaptation and assessment of a multi-level stigma mitigation intervention package designed to improve antiretroviral therapy (ART) adherence and viral suppression among women living with HIV (WLHIV) across the...
- Federal Grant Award Summary Yale University received a $483,825 Project Grant awarded on August 12, 2025, by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports a two-year research initiative concluding July 31, 2027, focused on elucidating the structural mechanisms of broadly neutralizing antibodies (BNAbs) targeting the membrane-proximal external region (MPER) of HIV-1 envelope...
- Federal Project Grant Award Summary The University of Pittsburgh has received a $206,326 Project Grant from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), effective April 1, 2026 through March 31, 2029. The award funds the development and implementation of the DONGHANH intervention, a culturally adapted stigma-reduction program designed for men who have sex with men (MSM) and healthcare providers in Vietnam. The project will...
- Federal Project Grant Award Summary Yale University received a $453,629 Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective July 8, 2025, through June 30, 2027. The award supports the development and application of PHAGE-SEQ, a novel high-throughput technology that combines phage display of nanobodies (camelid-derived heavy chain-only immunoglobulins) with DNA sequencing to comprehensively...
- Federal Project Grant Award Summary Yale University received a $491,700 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective September 3, 2025 through September 2, 2027. The award supports research investigating the role of cerebrospinal fluid (CSF) memory B cells in neuropathogenesis among people with HIV (PWH) on antiretroviral therapy (ART). The research addresses a critical knowledge gap regarding B...
Yale University received a $217,539 Project Grant from the Fogarty International Center (CFDA 93.989: International Research and Research Training) for a three-year project (April 1, 2026 – March 31, 2029) addressing HIV-related stigma among men who have sex with men (MSM) in Peru. The research deliverables include the development of a tailored same-day antiretroviral therapy (SD-ART) protocol utilizing asynchronous online focus groups and flowcharting techniques to map and streamline the treatment initiation process. The project will employ behavioral design intervention (BDI) methodologies that operate at the organizational level to minimize clinical interactions that reinforce stigma and delay antiretroviral therapy (ART) initiation. Key products from this initiative include a streamlined SD-ART protocol incorporating choice architecture principles and evidence-based framing scripts derived from mixed-methods research. Using nominal group techniques, the research team will assess multi-level barriers and facilitators to SD-ART from the perspectives of patients, clinicians, and administrators, generating actionable guidance for implementation. This work builds on established evidence that rapid-start ART significantly improves ART initiation, retention, and viral suppression among MSM populations, thereby advancing both individual and public health outcomes in Peru's concentrated HIV epidemic.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $56.5k | 2/19/26 | ||
| Not listed | $161.0k | 2/13/26 |